• estrogenic effects on bone and lipid metabolism

  • mediating anti-estrogenic effects on uterine endometrium and breast tissues.

  • CI: 10 yr Raloxifan

  • For OP - Osteoporosis

    • No hip fracture or non-vertebral fracture benefit

    Screenshot 2024-04-07 at 11.58.03 AM.png

    Screenshot 2024-04-07 at 11.57.58 AM.png